We’re seeking volunteers for our next 11-week, Opening Minds Through Arts (OMA) series. Once per week volunteers will be paired with older adults living with dementia to create abstract art projects ...

Half-life of approximately 100 days increases likelihood of once-per-year dosing Pharmacokinetic profile supports the ability ...

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industryBased on a novel ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Sedgeley speaks in an upbeat tone when reflecting on everything from the state of wolf reintroduction in Colorado to his side ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE ...

The $90 million project on the Ben Franklin Parkway breaks conventions by letting Alexander 'Sandy' Calder's work speak for itself.

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studiesIcotrokinra also showed ...

The brand conceives of itself as a distribution system for utopian values as much as a clothing company. Can it become the ...

Supriya Chakrabarti, Distinguished University Professor, Department of Physics and Applied Physics, University of Massachusetts Lowell and Director, Lowell Center for Space Science and Technology will ...

Half-life of approximately 100 days increases likelihood of once-per-year dosing Pharmacokinetic profile supports the ability to achieve exposures that could lead to higher efficacy and extended off-t ...

Introduction With the COVID-19 pandemic driving people into social isolation, causing a financial crisis and creating uncertainty, individuals were at an even greater risk of experiencing negative ...